8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): February 22, 2005

TLC Vision Corporation
__________________________________________
(Exact name of registrant as specified in its charter)

New Brunswick	0-29302	980151150
_____________________ (State or other jurisdiction	_____________ (Commission	______________ (I.R.S. Employer
of incorporation)	File Number)	Identification No.)
5280 Solar Drive, Suite 100, Mississauga, Ontario		L4W 5M8
_________________________________ (Address of principal executive offices)		___________ (Zip Code)

Registrant’s telephone number, including area code: (905) 602-2020

Not Applicable
______________________________________________
Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.01. Completion of Acquisition or Disposition of Assets.

On February 22, 2005 TLC Vision Corporation ("Company") issued a press release announcing that Midwest Surgical Services, Inc., a subsidiary of the Company, acquired the assets of Mobile Diagnostics Inc. A copy of the press release is attached hereto as an exhibit.

Item 9.01. Financial Statements and Exhibits.

99.1 Press Release dated February 22, 2005 announcing the purchase of assets of Mobile Diagnostics Inc.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	TLC Vision Corporation
February 24, 2005	By:	Steve Rasche
		Name: Steve Rasche
		Title: Chief Financial Officer

Exhibit Index

Exhibit No.	Description
99.1	Press Release Announcing the Acquisition of the Assets of Mobile Diagnostics Inc.

EX-99.1

News Release	Contact:
For Immediate Release	Anna Austin EVP, Corporate Communications

(314) 523-8354
investor.relations@tlcvision.com

TLCVision Acquires Assets of Mobile Diagnostics, Inc. for its Cataract Division

St. Louis, Missouri, February 22, 2005 –TLC Vision Corporation (NASDAQ:TLCV; TSX:TLC), North America’s premier eye care services company announced today that Midwest Surgical Services (MSS) acquired the assets of Mobile Diagnostics Inc. (MDI). MSS, TLCVision’s cataract subsidiary, is considered to be the largest cataract outsource service provider in the United States.

MDI, a Minnesota based corporation, provides mobile glaucoma scanning services to Optometrists and Ophthalmologists. Glaucoma is a group of eye diseases that can gradually cause loss of sight without warning and often without symptoms if not detected in time. It affects over 3 million Americans.

MDI’s services provide early detection and management of glaucoma. The GDx VCC exams provide the earliest possible detection of glaucoma by measuring the health of the retinal nerve layer. The Ocular Blood Flow Analyzer records ocular blood flow data, providing information about the vascular network of the eye.

“This acquisition is consistent with our strategy to diversify our eye care services business. Glaucoma diagnostic capability broadens our offering and allows us to expand and further leverage our current doctor relationships”, commented Jim Wachtman, President and Chief Executive Officer.

About TLCVision

TLCVision is North America’s premier eye care services company. The key drivers of TLCVision’s strategy are our affiliated network of thousands of eye doctors, proven corporate and consumer marketing and education programs, and access to state of the art clinical technologies. We are supported by a strong operations management culture and superior information technology. More information about the company can be found on the TLCVision web site at www.tlcv.com.

Forward Looking Statements
This press release contains certain forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933 and Section 21E of the U.S. Securities Exchange Act of 1934, which statements can be identified by the use of forward looking terminology, such as “may,” “will,” “expect,” “intend, “anticipate,” “estimate,” “predict,” “plans” or “continue” or the negative thereof or other variations thereon or comparable terminology referring to future events or results. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of numerous factors, including the timing of expenditures, effects of competition, changes to pricing, acquisitions and expansion opportunities, any of which could cause actual results to vary materially from current results of TLCVision‘s anticipated future results. See the Company’s reports filed with the Canadian Securities Regulators and the U.S. Securities and Exchange Commission from time to time for cautionary statements identifying important factors with respect to such forward looking statements, including certain risks and uncertainties, that could cause actual results to differ materially from results referred to in forward looking statements. TLCVision assumes no obligation to update the information contained in this press release.